IP Library Assignment 047089/0675
Patent Assignment
Reel/Frame 047089/0675

Release and Reassignment of Security Interest Recorded at Reel/Frame 41277/0753

Recorded: 2018-09-13 Pages: 6
Assignor
NXT CAPITAL, LLC
Executed: 2018-08-02
Assignee
TRILINK BIOTECHNOLOGIES, LLC
9955 MEGA RIM ROAD, SAN DIEGO, CALIFORNIA, 92121
Covered Properties (6)
Pre-activated carbonyl linkers for the modification of Oligonucleotides
Patent: 6,320,041 →
Application: 09/834,828 →
Phosphotriester-Modified Oligonucleotide Primers for Nucleic Acid Amplification
Patent: 8,361,753 →
Application: 11/750,237 →
Publication: US 2007/0281308
Chemically Modified Nucleoside 5'-Triphosphates for Thermally Initiated Amplification of Nucleic Acid
Patent: 8,133,669 →
Application: 12/470,449 →
Publication: US 2010/0003724
Chemically Modified Ligase Cofactors, Donors and Acceptors
Patent: 8,728,725 →
Application: 12/831,212 →
Publication: US 2011/0008788
Chemically Modified Ligase Cofactors, Donors and Acceptors
Patent: 9,631,227 →
Application: 13/833,600 →
Publication: US 2014/0323354
Compositions and Methods for Synthesizing 5'-Capped RNAs
Application: 62/221,248 →
Related Assignments (12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 26, 2014
From: PAUL, NATASHA; SHORE, SABRINA; SHUM, JONATHAN; LEBEDEV, ALEXANDRE
To: TRILINK BIOTECHNOLOGIES, INC.
Reel/Frame 032307/0071 →
Assignment of Assignor's Interest Feb 26, 2014
From: PAUL, NATASHA; SHUM, JONATHAN; LEBEDEV, ALEXANDRE; ZON, GERALD
To: TRILINK BIOTECHNOLOGIES
Reel/Frame 032303/0295 →
Assignment of Assignor's Interest Dec 11, 2015
From: LEBEDEV, ALEXANDRE, DR.; SHIN, DONGWON, MR.; MCCAFFREY, ANTON P., DR.; HOGREFE, RICHARD I., DR.
To: TRILINK BIOTECHNOLOGIES, INC.
Reel/Frame 037269/0748 →
Security Interest Feb 16, 2017
From: TRILINK BIOTECHNOLOGIES, LLC
To: NXT CAPITAL, LLC, AS AGENT
Reel/Frame 041277/0753 →
Security Agreement Aug 2, 2018
From: TRILINK BIOTECHNOLOGIES; TRILINK BIOTECHNOLOGIES, INC.; TRILINK BIOTECHNOLOGIES, LLC; GLEN RESEARCH CORPORATION
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 046708/0095 →
Security Agreement Aug 3, 2018
From: TRILINK BIOTECHNOLOGIES; TRILINK BIOTECHNOLOGIES, INC.; TRILINK BIOTECHNOLOGIES, LLC; GLEN RESEARCH CORPORATION
To: ANTARES CAPITAL LP, AS COLLATERAL AGENT
Reel/Frame 046702/0651 →
Security Agreement Oct 19, 2020
From: MARAVAI LIFE SCIENCES, INC.; TRILINK BIOTECHNOLOGIES, LLC; VECTOR LABORATORIES, INC.; GLEN RESEARCH, LLC
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 054118/0848 →
Release of Second Lien Security Interest Oct 19, 2020
From: ANTARES CAPITAL LP
To: VECTOR LABORATORIES, INC.; TRILINK BIOTECHNOLOGIES, LLC; GLEN RESEARCH, LLC
Reel/Frame 054118/0763 →
Release of First Lien Security Interest Oct 19, 2020
From: JPMORGAN CHASE BANK, N.A.
To: VECTOR LABORATORIES, INC.; TRILINK BIOTECHNOLOGIES, LLC; GLEN RESEARCH, LLC
Reel/Frame 054118/0751 →
Change of Name Jul 29, 2022
From: TRILINK BIOTECHNOLOGIES, INCORPORATED
To: TRILINK BIOTECHNOLOGIES, LLC
Reel/Frame 061033/0215 →
Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 022142 Frame: 0111. Assignor(S) Hereby Confirms the Assignment. Sep 27, 2022
From: ZON, GERALD; LEBEDEV, ALEXANDRE
To: TRILINK BIOTECHNOLOGIES, INCORPORATED
Reel/Frame 061553/0775 →
Change of Name Dec 14, 2022
From: TRILINK BIOTECHNOLOGIES, INCORPORATED
To: TRILINK BIOTECHNOLOGIES, LLC
Reel/Frame 062124/0819 →